Quick Answer
PAVmed Inc. reported Operating Income of -$21.81 million for fiscal year 2025.
PAVmed Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$21.81M | +51.0% |
| 2024 | -$44.49M | +35.3% |
| 2023 | -$68.80M | +24.5% |
| 2022 | -$91.09M | -67.5% |
| 2021 | -$54.39M | -132.9% |
| 2020 | -$23.35M | -63.4% |
| 2019 | -$14.29M | -35.3% |
| 2018 | -$10.56M | -31.5% |
| 2017 | -$8.03M | -42.2% |
| 2016 | -$5.65M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.84M | +58.2% | -2.7% |
| June 30, 2025 | -$4.71M | +65.5% | +13.4% |
| March 31, 2025 | -$5.45M | +61.2% | +53.0% |
| September 30, 2024 | -$11.58M | +25.4% | +15.4% |
| June 30, 2024 | -$13.68M | +17.0% | +2.5% |
| March 31, 2024 | -$14.04M | +31.2% | +9.6% |
| September 30, 2023 | -$15.53M | +33.5% | +5.8% |
| June 30, 2023 | -$16.48M | +29.8% | +19.2% |
- PAVmed Inc. showed an increase of +51.0% in Operating Income compared to the prior fiscal year.
- Over the 2016–2025 period, PAVmed Inc.’s operating income has declined by 285.9% (from -$5.65 million to -$21.81 million).
- The most recent figure is from PAVmed Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: